Michael Matson
Stock Analyst at Needham
(2.61)
# 2,277
Out of 5,046 analysts
23
Total ratings
69.23%
Success rate
11.46%
Average return
Main Sectors:
Stocks Rated by Michael Matson
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| TFX Teleflex | Maintains: Buy | $408 → $423 | $124.47 | +239.84% | 4 | Jan 31, 2020 | |
| INGN Inogen | Upgrades: Buy | $90 | $8.25 | +990.91% | 2 | Nov 6, 2019 | |
| MMSI Merit Medical Systems | Initiates: Buy | $53 | $87.41 | -39.37% | 1 | Apr 20, 2018 | |
| GMED Globus Medical | Upgrades: Buy | n/a | $60.39 | - | 1 | Apr 4, 2018 | |
| RMD ResMed | Upgrades: Hold | n/a | $246.88 | - | 1 | Jan 23, 2018 | |
| BSX Boston Scientific | Upgrades: Strong Buy | n/a | $100.72 | - | 1 | Dec 8, 2017 | |
| LIVN LivaNova | Upgrades: Buy | n/a | $52.63 | - | 2 | Sep 15, 2017 | |
| SYK Stryker | Upgrades: Hold | n/a | $356.24 | - | 4 | Aug 25, 2017 | |
| MBLY Mobileye Global | Downgrades: Hold | n/a | $13.15 | - | 1 | Mar 14, 2017 | |
| HOLX Hologic | Upgrades: Buy | n/a | $73.91 | - | 2 | Feb 15, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $79.34 | - | 1 | Aug 12, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $1.40 | - | 1 | Mar 3, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $2.26 | - | 1 | Feb 24, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | n/a | $199.33 | - | 1 | Jan 29, 2016 |
Teleflex
Jan 31, 2020
Maintains: Buy
Price Target: $408 → $423
Current: $124.47
Upside: +239.84%
Inogen
Nov 6, 2019
Upgrades: Buy
Price Target: $90
Current: $8.25
Upside: +990.91%
Merit Medical Systems
Apr 20, 2018
Initiates: Buy
Price Target: $53
Current: $87.41
Upside: -39.37%
Globus Medical
Apr 4, 2018
Upgrades: Buy
Price Target: n/a
Current: $60.39
Upside: -
ResMed
Jan 23, 2018
Upgrades: Hold
Price Target: n/a
Current: $246.88
Upside: -
Boston Scientific
Dec 8, 2017
Upgrades: Strong Buy
Price Target: n/a
Current: $100.72
Upside: -
LivaNova
Sep 15, 2017
Upgrades: Buy
Price Target: n/a
Current: $52.63
Upside: -
Stryker
Aug 25, 2017
Upgrades: Hold
Price Target: n/a
Current: $356.24
Upside: -
Mobileye Global
Mar 14, 2017
Downgrades: Hold
Price Target: n/a
Current: $13.15
Upside: -
Hologic
Feb 15, 2017
Upgrades: Buy
Price Target: n/a
Current: $73.91
Upside: -
Aug 12, 2016
Downgrades: Hold
Price Target: n/a
Current: $79.34
Upside: -
Mar 3, 2016
Downgrades: Neutral
Price Target: n/a
Current: $1.40
Upside: -
Feb 24, 2016
Downgrades: Hold
Price Target: n/a
Current: $2.26
Upside: -
Jan 29, 2016
Upgrades: Buy
Price Target: n/a
Current: $199.33
Upside: -